MedPath

ARGENX AUSTRALIA PTY. LTD.

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

TGA:2

Drug Approvals

VYVGART efgartigimod alfa 1000 mg/5.6 mL solution for injection vial (444954)

Product Name
VYVGART efgartigimod alfa 1000 mg/5.6 mL solution for injection vial
Approval Date
Feb 24, 2025
TGA

VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial (444955)

Product Name
VYVGART efgartigimod alfa 400 mg/20 mL concentrated injection for intravenous infusion vial
Approval Date
Feb 24, 2025
TGA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.